Vaccine in the UK
LONDON (Reuters) – The UK drug regulatory agency said on Thursday there were 168 major cases of thrombosis after a single dose of the AstraZeneca Covit-19 vaccine was used, a code of 7.9 per million. The number of the previous week.
100 cases were reported last week, with the total number of cases being 4.9 tumors per million doses.
The astrogenic vaccine has become a surveillance target for very rare tumors, and some countries, including the United Kingdom, recommend vaccinating only those over a certain age.
Adam Finn, professor of pediatrics at the University of Bristol, said an increase in reported cases was expected.
“Cases are reported reliably and quickly, but cases that have occurred before are now recognized and reported,” Finn said.
“As these reports are confirmed, I hope the true number of one million vaccines will become clear very soon, but it is already clear that this will continue to be a very rare occurrence.”
The UK has already distributed the first 21.2 million doses of the astrogenic vaccine, and all reports of side effects came after the first dose, with the exception of one. The total number of second dose administered was not reported.
(Written by Alistair Smout)
See also
+ Career of the Decade – See how to enter life without professionals, but in vacancies
+ The lemon squeeze trick is a cross on social media
+ Woman goes to jail for pretending to be an FBI agent to get free food
The digital blue zone in SP changes on the 16th; See how it is
+ Study reveals healthy method of cooking rice
+ Can doing a lot of belching be a health issue?
+ Shark caught in MA with remnants of missing youth in stomach
+ Cinema, sex and the city
+ 6,500-year-old copper workshop discovered in the desert of Israel
Henry Blackwell is a contributor at Mediarunsearch.co.uk, covering a wide range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. He focuses on delivering clear, balanced reporting and useful information that helps readers stay informed about current events and emerging developments. His work highlights stories that matter to everyday audiences, with an emphasis on accuracy, relevance, and accessible journalism.